About the FoundationProgramsUnderstanding AngiogenesisContinuing Medical EducationR4 2008 DocumentsDonate to the Angiogenesis FoundationContact Us
NEWS
  FDA Approves the First Antiangiogenic Therapy for Pet Dogs with Cancer
 June 18, 2009

The FDA has approved the drug toceranib (Palladia), a new medication that interferes with the formation of tumor blood vessels (angiogenesis), for use by veterinarians to treat pet dogs with mast cell cancer. This is the first cancer agent specifically approved for use in dogs. The drug comes in pill form and is expected to be available in early 2010. This is the first cancer agent specifically approved for use in dogs... Read More 

"Imagine that one medical advancement held the promise to conquer cancer, perhaps within your lifetime. Now imagine that same advance has the potential to also end more than 70 of life's most threatening conditions, affecting one billion people worldwide. This is the promise of angiogenesis, the first medical revolution of the 21st century."

Dr. William Li
President and Medical Director
The Angiogenesis Foundation

Hear from the Experts

Tribute to Dr. Judah Folkman

 
© 2009 The Angiogenesis Foundation. All Rights Reserved.